Selected highlights from the 50(th) Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001

The recent scientific session of the American College of Cardiology (ACC), held in Orlando, provided a forum for ongoing cardiovascular clinical trials from around the world. The high point was clearly the first ever release of results from the CURE study. The Late-Breaking Clinical Trials sessions...

Descripción completa

Detalles Bibliográficos
Autor principal: Lyford, Joanna
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59630/
https://www.ncbi.nlm.nih.gov/pubmed/11806778
http://dx.doi.org/10.1186/cvm-2-2-085
_version_ 1782120089580994560
author Lyford, Joanna
author_facet Lyford, Joanna
author_sort Lyford, Joanna
collection PubMed
description The recent scientific session of the American College of Cardiology (ACC), held in Orlando, provided a forum for ongoing cardiovascular clinical trials from around the world. The high point was clearly the first ever release of results from the CURE study. The Late-Breaking Clinical Trials sessions also featured results and interim data from other trials such as MIRACLE, CAPRICORN, SVG WRIST, RITZ 2, SoS and PRINCE. New applications for data from the OPUS-TIMI16 trial were discussed and promising results from initial studies into the experimental drug ALT-711 showed the way for further studies.
format Text
id pubmed-59630
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-596302001-11-06 Selected highlights from the 50(th) Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001 Lyford, Joanna Curr Control Trials Cardiovasc Med Meeting Report The recent scientific session of the American College of Cardiology (ACC), held in Orlando, provided a forum for ongoing cardiovascular clinical trials from around the world. The high point was clearly the first ever release of results from the CURE study. The Late-Breaking Clinical Trials sessions also featured results and interim data from other trials such as MIRACLE, CAPRICORN, SVG WRIST, RITZ 2, SoS and PRINCE. New applications for data from the OPUS-TIMI16 trial were discussed and promising results from initial studies into the experimental drug ALT-711 showed the way for further studies. BioMed Central 2001 2001-04-11 /pmc/articles/PMC59630/ /pubmed/11806778 http://dx.doi.org/10.1186/cvm-2-2-085 Text en Copyright © 2001 BioMed Central Ltd
spellingShingle Meeting Report
Lyford, Joanna
Selected highlights from the 50(th) Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001
title Selected highlights from the 50(th) Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001
title_full Selected highlights from the 50(th) Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001
title_fullStr Selected highlights from the 50(th) Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001
title_full_unstemmed Selected highlights from the 50(th) Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001
title_short Selected highlights from the 50(th) Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001
title_sort selected highlights from the 50(th) annual scientific session of the american college of cardiology, orlando, usa, 18-21 march 2001
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59630/
https://www.ncbi.nlm.nih.gov/pubmed/11806778
http://dx.doi.org/10.1186/cvm-2-2-085
work_keys_str_mv AT lyfordjoanna selectedhighlightsfromthe50thannualscientificsessionoftheamericancollegeofcardiologyorlandousa1821march2001

Ejemplares similares